In this episode of Humanitarian Horizons, Christina DiArcangelo examines the lasting impact of the pandemic through the lens of patient advocacy, pharmaceutical development, regulatory affairs, and healthcare leadership.

Drawing on her own experience working in regulated drug development during the COVID-19 era, Christina discusses the challenges researchers, innovators, and healthcare professionals faced while navigating rapidly evolving policies, scientific uncertainty, and public debate.


Topics discussed include:

• Public trust in healthcare institutions

• Scientific transparency

• COVID-19 public health policies

• Social media moderation and scientific discourse

• Regulatory challenges during the pandemic

• Patient advocacy



This episode also explores the importance of accountability, open scientific dialogue, evidence-based decision making, and protecting innovation while maintaining public confidence in healthcare systems.

Humanitarian Horizons is dedicated to discussing healthcare, patient advocacy, public policy, leadership, and humanitarian issues that shape our world.

Subscribe for more conversations on healthcare leadership, patient advocacy, regulatory affairs, innovation, and public health.

COVID, COVID-19, pandemic, public trust, healthcare, scientific transparency, scientific accountability, FDA, drug development, clinical research, patient advocacy, public health, healthcare leadership, medical ethics, regulatory affairs, Christina DiArcangelo, Humanitarian Horizons, vaccine mandates, scientific debate, innovation, pharmaceutical industry, clinical trials, public policy, healthcare policy, scientific integrity, social media censorship, medical innovation, FDA regulations, drug approval, patient rights, united states

#covid19 #publichealth #healthcare #patientadvocacy #scientificintegrity #leadership #fda #clinicalresearch #healthcareleadership #HumanitarianHorizons #unitedstates